大参林：8月28日召开董事会会议

Group 1 - The company Dazhenglin (SH 603233) announced the convening of its 27th meeting of the fourth board of directors on August 28, 2025, via communication methods [1] - The meeting reviewed the proposal regarding the company's half-year report and summary for 2025 [1] - For the first half of 2025, Dazhenglin's revenue composition was as follows: retail pharmacy accounted for 81.38%, wholesale pharmacy accounted for 15.8%, and other businesses accounted for 2.82% [1]